What's Their Growth Strategy?

Latest annual report has their strategy:

To me seems on the lower end of the yoga-babble 🐂💩 scale, but I haven't analysed many of these so interested to hear thoughts (for any of the posts I make of course).

"Focusing on the following business strategies[...]:

• Establishing and maintaining our technology platform as the leading approach to CGM and leveraging our development expertise to rapidly bring products to market, including for expanded indications.

• Supporting use of our ambulatory products through a direct sales and marketing effort, as well as key distribution arrangements.

• Supporting innovation through technology integration partnerships.

• Seeking broad coverage policies and reimbursement for our products from private third-party payors and national health systems.

• Providing cloud-based data repository platform that enables people with diabetes to aggregate and analyze data from numerous diabetes devices and share the data with their healthcare providers and other individuals involved in their diabetes management and care.

• Pursuing expansion of use of our products to other patient care settings and patient demographics, including use for people with Type 2 diabetes who are not on intensive insulin therapy, population health, patient monitoring including in the hospital setting, and people who are pregnant.

• Providing a high level of customer support, service and education.

• Pursuing the highest safety and quality levels for our products."